Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Naresh Kumar Meena

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
Annals of Translational Medicine|August 9, 2019
Pros and cons of different ways to address dysfunctional autophagy in Pompe diseaseJeong-A Lim, Naresh Kumar Meena, Nina Raben
Molecular Therapy. Methods & Clinical Development|July 17, 2020
Enzyme Replacement Therapy Can Reverse Pathogenic Cascade in Pompe DiseaseNaresh Kumar Meena, Evelyn Ralston, Nina Raben, et al.
Plos One|March 20, 2015
Association of TLR5 gene polymorphisms in ulcerative colitis patients of north India and their role in cytokine homeostasisNaresh Kumar Meena, Vineet Ahuja, Kusumlata Meena, et al.
Plos One|September 8, 2017
Correction: Association of miR-196a-2 and miR-499 variants with ulcerative colitis and their correlation with expression of respective miRNAsRaju Ranjha, Naresh Kumar Meena, Abhiraman Singh, et al.
Plos One|March 17, 2017
Association of miR-196a-2 and miR-499 variants with ulcerative colitis and their correlation with expression of respective miRNAsRaju Ranjha, Naresh Kumar Meena, Abhiraman Singh, et al.
Immunology|August 26, 2018
mTORC1 activation in B cells confers impairment of marginal zone microarchitecture by exaggerating cathepsin activityNaresh Kumar Meena, Shakti Prasad Pattanayak, Yael Ben-Nun, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
Annals of Translational Medicine|August 9, 2019
Pros and cons of different ways to address dysfunctional autophagy in Pompe diseaseJeong-A Lim, Naresh Kumar Meena, Nina Raben
Molecular Therapy. Methods & Clinical Development|July 17, 2020
Enzyme Replacement Therapy Can Reverse Pathogenic Cascade in Pompe DiseaseNaresh Kumar Meena, Evelyn Ralston, Nina Raben, et al.
Plos One|March 20, 2015
Association of TLR5 gene polymorphisms in ulcerative colitis patients of north India and their role in cytokine homeostasisNaresh Kumar Meena, Vineet Ahuja, Kusumlata Meena, et al.
Plos One|September 8, 2017
Correction: Association of miR-196a-2 and miR-499 variants with ulcerative colitis and their correlation with expression of respective miRNAsRaju Ranjha, Naresh Kumar Meena, Abhiraman Singh, et al.
Plos One|March 17, 2017
Association of miR-196a-2 and miR-499 variants with ulcerative colitis and their correlation with expression of respective miRNAsRaju Ranjha, Naresh Kumar Meena, Abhiraman Singh, et al.
Immunology|August 26, 2018
mTORC1 activation in B cells confers impairment of marginal zone microarchitecture by exaggerating cathepsin activityNaresh Kumar Meena, Shakti Prasad Pattanayak, Yael Ben-Nun, et al.
Pageof 1